Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MCRB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $27.32M
- EPS (TTM)
- -$2.24
- Dividend yield
- None
- 52-week range
- 2.70 – 29.98
- Day range
- 2.70 – 3.00
- Volume / Avg
- 60.37K / 72.19K
- Beta
- —
- Shares outstanding
- 10.04M
- Next earnings
- Nov 4, 2026
52-week range
MCRB stock today
Seres Therapeutics (MCRB) closed at $2.72 on Oct 7, down 6.21% (-$0.18), versus the S&P 500's 0.22% decline. At this level, MCRB sits near the bottom of its 52-week range of $2.70 to $29.98: 90.9% below the high and 0.7% above the low. Seres Therapeutics has posted a net loss over the last twelve months (EPS of -$2.24), so its P/E ratio is not meaningful.
Seres Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Seres Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-1.34
Seres Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABVCABVC BioPharma Inc. | 1.00 | +3.09% | $26.69M | vs MCRB |
| BYSIBeyondSpring Inc. | 0.6445 | -6.90% | $26.50M | vs MCRB |
| CNTXContext Therapeutics Inc. | 0.3126 | -2.86% | $28.72M | vs MCRB |
| IGCIGC Pharma Inc. | 0.28 | 0.00% | $28.95M | vs MCRB |
| GRDXGridAI Technologies Corp. | 4.12 | -1.20% | $29.38M | vs MCRB |
| RNAZTransCode Therapeutics Inc. | 1.76 | -1.12% | $29.80M | vs MCRB |
| KYNBKyntra Bio Inc. | 6.13 | +2.85% | $24.82M | vs MCRB |
| MIRAMIRA Pharmaceuticals Inc. | 0.71 | -0.25% | $29.84M | vs MCRB |
Indexes, lists and sector
Seres Therapeutics stock FAQ
What is Seres Therapeutics's stock price today?
MCRB last traded at $2.72 as of Oct 7, 4:00 PM EDT, down 6.21% on the day. Prices are delayed at least 15 minutes.
When is Seres Therapeutics's next earnings date?
Seres Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-1.34.
What is the MCRB 52-week high?
The 52-week high for MCRB is $29.98 and the 52-week low is $2.70. The stock is currently 90.9% below its high.